Skip to content

Thrombolysis in STEMI Patients Compared With pPCI on Recanalization Time in the Context of the COVID-19 Outbreak.

Intravenous Thrombolysis Versus Primary PCI for Recanalization Time in Acute ST-segment Elevation Myocardial Infarction in the Context of the COVID-19 Outbreak: a Prospective, Multicenter, Nonrandomized Controlled Registry Study.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05354128
Acronym
RESCUE-STEMI
Enrollment
120
Registered
2022-04-29
Start date
2022-04-01
Completion date
2023-04-30
Last updated
2022-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STEMI - ST Elevation Myocardial Infarction

Brief summary

During the outbreak of COVID-19, for patients with acute ST-segment elevation myocardial infarction with unclear infection, the time of primary PCI is uncertain, and it is often expected to exceed 90 minutes or even 120 minutes. In indicated patients, intravenous thrombolysis has significantly improved the recanalization time of criminal vessels.

Detailed description

During the outbreak of COVID-19, for patients with acute ST-segment elevation myocardial infarction with unclear infection, the time of primary PCI is uncertain, and it is often expected to exceed 90 minutes or even 120 minutes. In indicated patients, intravenous thrombolysis has significantly improved the recanalization time of criminal vessels. The purpose of this study was to compare the time from first medical contact to patency and safety (specifically symptom improvement, ECG ST segment) between intravenous thrombolysis and concurrent patients with possible primary PCI in a prospective, multicenter, non-randomized controlled manner. Significant fall, angiographic examination showed criminal blood vessel TIMI blood flow grade 2-3)

Interventions

Standard intravenous thrombolysis.

Percutaneous coronary stenting

Sponsors

Ya-Wei Xu
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

non-randomized control

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* ECG confirms acute ST-segment elevation myocardial infarction;The estimated time from FMC to recanalization is more than 120 minutes;

Exclusion criteria

* Intracranial hemorrhage or stroke within the past 6 months; central nervous system injury, tumor or arteriovenous malformation; bleeding disease with known cause; suspected aortic dissection; non-compressible puncture surgery within 24 hours, etc.; 1 week of pregnancy or postpartum; uncontrolled hypertension; advanced liver disease; active peptic ulcer; prolonged or invasive CPR;

Design outcomes

Primary

MeasureTime frameDescription
recanalizationwithin 24 hoursCoronary angiography to check for recanalization after thrombolysis(Yes or No)
recanalization timewithin 2 hoursFrom first medical contact(FMC) time to recanalization time.

Secondary

MeasureTime frameDescription
Major bleeding event7 dayWhether there is a major bleeding event with drug thrombolysis(Yes or No)
Malignant arrhythmia12 hoursMalignant arrhythmia incidence

Countries

China

Contacts

Primary ContactJun Zhang, Doctor
zhangjun_njmu2011@163.com+86 15000420881

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026